Coimbra Genomics Company
%20.jpg)
Coimbra Genomics, S.A. has developed and is commercializing ELSIE, a first-in-class digital platform that allows physicians of any speciality to use information on their patient’s genome during a regular medical appointment. By combining the capacity to provide fast, accurate, on-the-spot answers based on each patient’s genome with an efficient articulation with multiple providers of specific genetic tests, ELSIE is the first simple, highly scalable and completely secure way to perform personalized medicine.
%20.jpg)
Headquarters:
Cantanhede, Coimbra, Portugal
Total Funding:
€4.7M
Last Funding Type:
Series A
Founded Date:
2013-01-01
Technology:
Others
Estimated Revenue:
$1M to $10M
Industry:
Biotechnology, Health Care, Science and Engineering
Investor Type:
For Profit
Funding Status:
Early Stage Venture
Investors Number:
3
Employee Number:
1-10